COVID19 - Infectious Disease Advisor

COVID-19

COVID-19

FDA: SARS-CoV-2 Mutations May Impact Molecular Tests

The FDA is alerting clinical laboratory staff and health care providers regarding the risk of false negative results with any SARS-CoV-2 test if a mutation occurs in the part of the virus’ genome assessed by that test.
Next post in COVID19